MX2023001142A - Composiciones y metodos para analisis de acidos nucleicos. - Google Patents

Composiciones y metodos para analisis de acidos nucleicos.

Info

Publication number
MX2023001142A
MX2023001142A MX2023001142A MX2023001142A MX2023001142A MX 2023001142 A MX2023001142 A MX 2023001142A MX 2023001142 A MX2023001142 A MX 2023001142A MX 2023001142 A MX2023001142 A MX 2023001142A MX 2023001142 A MX2023001142 A MX 2023001142A
Authority
MX
Mexico
Prior art keywords
methods
compositions
base
nucleic acid
acid analysis
Prior art date
Application number
MX2023001142A
Other languages
English (en)
Inventor
Michael Steward
Oliver Nentwich
Sidong Liu
Shankar Balasubramanian
Jens Fullgrabe
Walraj Singh Gosal
Joanna Dawn Holbrook
David Morley
Tobias Ost
Albert Vilella
Nicholas James Walker
Shirong Yu
Helen Rachel Bignell
Rita Santo San-Bento
Original Assignee
Cambridge Epigenetix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Epigenetix Ltd filed Critical Cambridge Epigenetix Ltd
Publication of MX2023001142A publication Critical patent/MX2023001142A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1058Directional evolution of libraries, e.g. evolution of libraries is achieved by mutagenesis and screening or selection of mixed population of organisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811Selection methods for production or design of target specific oligonucleotides or binding molecules
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2521/00Reaction characterised by the enzymatic activity
    • C12Q2521/10Nucleotidyl transfering
    • C12Q2521/125Methyl transferase, i.e. methylase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2521/00Reaction characterised by the enzymatic activity
    • C12Q2521/50Other enzymatic activities
    • C12Q2521/513Winding/unwinding enzyme, e.g. helicase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2521/00Reaction characterised by the enzymatic activity
    • C12Q2521/50Other enzymatic activities
    • C12Q2521/531Glycosylase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2521/00Reaction characterised by the enzymatic activity
    • C12Q2521/50Other enzymatic activities
    • C12Q2521/539Deaminase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2523/00Reactions characterised by treatment of reaction samples
    • C12Q2523/10Characterised by chemical treatment
    • C12Q2523/115Characterised by chemical treatment oxidising agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2523/00Reactions characterised by treatment of reaction samples
    • C12Q2523/10Characterised by chemical treatment
    • C12Q2523/125Bisulfite(s)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/30Oligonucleotides characterised by their secondary structure
    • C12Q2525/301Hairpin oligonucleotides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Ecology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

En la presente se proporcionan métodos, sistemas, y composiciones para determinar una base en un polinucleótido. En diversos aspectos, los métodos, sistemas, y composiciones, presentados en la presente son útiles para realizar secuenciación de 4 bases, 5 bases, o 6 bases de moléculas de polinucleótidos, por ejemplo, a partir de muestras de biopsia líquidas o en donde la base es una mutación de baja frecuencia.
MX2023001142A 2020-07-30 2021-07-29 Composiciones y metodos para analisis de acidos nucleicos. MX2023001142A (es)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US202063058712P 2020-07-30 2020-07-30
US202063061093P 2020-08-04 2020-08-04
US202063105860P 2020-10-26 2020-10-26
US202063106566P 2020-10-28 2020-10-28
US202163152976P 2021-02-24 2021-02-24
US202163178386P 2021-04-22 2021-04-22
US202163210927P 2021-06-15 2021-06-15
US202163212500P 2021-06-18 2021-06-18
US202163213626P 2021-06-22 2021-06-22
US202163215752P 2021-06-28 2021-06-28
PCT/GB2021/051957 WO2022023753A1 (en) 2020-07-30 2021-07-29 Compositions and methods for nucleic acid analysis

Publications (1)

Publication Number Publication Date
MX2023001142A true MX2023001142A (es) 2023-05-25

Family

ID=77338694

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023001142A MX2023001142A (es) 2020-07-30 2021-07-29 Composiciones y metodos para analisis de acidos nucleicos.

Country Status (10)

Country Link
US (3) US11608518B2 (es)
EP (2) EP4083231A1 (es)
JP (1) JP2023535636A (es)
KR (1) KR20230083269A (es)
CN (1) CN116323977A (es)
AU (1) AU2021319150A1 (es)
CA (1) CA3187549A1 (es)
IL (1) IL300238A (es)
MX (1) MX2023001142A (es)
WO (1) WO2022023753A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022023753A1 (en) 2020-07-30 2022-02-03 Cambridge Epigenetix Limited Compositions and methods for nucleic acid analysis
AU2022240477A1 (en) * 2021-03-15 2022-11-10 Illumina Cambridge Limited Detecting methylcytosine and its derivatives using S-adenosyl-L-methionine analogs (xSAMs)
WO2023168300A1 (en) * 2022-03-01 2023-09-07 Guardant Health, Inc. Methods for analyzing cytosine methylation and hydroxymethylation
WO2024069581A1 (en) * 2022-09-30 2024-04-04 Illumina Singapore Pte. Ltd. Helicase-cytidine deaminase complexes and methods of use

Family Cites Families (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9907812D0 (en) * 1999-04-06 1999-06-02 Medical Biosystems Ltd Sequencing
DE10019058A1 (de) 2000-04-06 2001-12-20 Epigenomics Ag Detektion von Variationen des DNA-Methylierungsprofils
DE10056802B4 (de) 2000-11-14 2005-06-16 Epigenomics Ag Verfahren zur Detektion von Methylierungszuständen zur toxikologischen Diagnostik
US20040054162A1 (en) 2001-10-30 2004-03-18 Hanna Michelle M. Molecular detection systems utilizing reiterative oligonucleotide synthesis
DE10214232A1 (de) 2002-03-25 2003-10-23 Epigenomics Ag Verfahren und Vorrichtung für die DNA Methylierungsanalyse
EP1568786A3 (en) 2004-02-13 2007-08-29 Affymetrix, Inc. (A US Entity) Analysis of methylation status using nucleic acid arrays
WO2006039563A2 (en) 2004-09-30 2006-04-13 Epigenomics Ag Method for providing dna fragments derived from an archived sample
US7449297B2 (en) 2005-04-14 2008-11-11 Euclid Diagnostics Llc Methods of copying the methylation pattern of DNA during isothermal amplification and microarrays
PT1871912E (pt) 2005-04-15 2012-05-25 Epigenomics Ag Método para determinar metilação de adn em amostras de sangue ou urina
US20070269824A1 (en) 2006-03-02 2007-11-22 Jeffrey Albrecht Methods and systems for evaluating health risk factors by measurement of DNA damage and DNA repair
US7820385B2 (en) 2006-03-22 2010-10-26 The United States Of America As Represented By The Department Of Health And Human Services, Centers For Disease Control And Prevention Method for retaining methylation pattern in globally amplified DNA
WO2008017411A2 (en) 2006-08-08 2008-02-14 Epigenomics Ag A method for methylation analysis of nucleic acid
JP2008212009A (ja) * 2007-02-28 2008-09-18 Sysmex Corp Dnaメチル化検出用試料の調製方法
US20100197510A1 (en) 2007-03-08 2010-08-05 Michael Spain Methods for rapid disease screening
WO2009092035A2 (en) 2008-01-17 2009-07-23 Sequenom, Inc. Methods and compositions for the analysis of biological molecules
ES2532883T3 (es) 2008-06-12 2015-04-01 Institut National De La Sante Et De La Recherche Medicale (Inserm) TET2 como nuevo marcador de diagnóstico y de pronóstico en neoplasias hematopoyéticas
WO2010037001A2 (en) 2008-09-26 2010-04-01 Immune Disease Institute, Inc. Selective oxidation of 5-methylcytosine by tet-family proteins
EP2340314B8 (en) 2008-10-22 2015-02-18 Illumina, Inc. Preservation of information related to genomic dna methylation
US9175338B2 (en) 2008-12-11 2015-11-03 Pacific Biosciences Of California, Inc. Methods for identifying nucleic acid modifications
WO2010068289A2 (en) 2008-12-11 2010-06-17 Pacific Biosciences Of California, Inc. Classification of nucleic acid templates
EP2376632B1 (en) 2008-12-23 2016-11-02 New England Biolabs, Inc. Compositions, methods and related uses for cleaving modified dna
LT5708B (en) 2009-04-02 2011-01-25 Biotechnologijos Inst Derivatization of biomolecules by covalent coupling of non-cofactor compounds using methyltransferases
US8986928B2 (en) 2009-04-10 2015-03-24 Pacific Biosciences Of California, Inc. Nanopore sequencing devices and methods
WO2011025819A1 (en) 2009-08-25 2011-03-03 New England Biolabs, Inc. Detection and quantification of hydroxymethylated nucleotides in a polynucleotide preparation
WO2011091146A1 (en) 2010-01-20 2011-07-28 New England Biolabs, Inc. Compositions, methods and related uses for cleaving modified dna
WO2011127136A1 (en) 2010-04-06 2011-10-13 University Of Chicago Composition and methods related to modification of 5-hydroxymethylcytosine (5-hmc)
US20120064521A1 (en) 2010-09-09 2012-03-15 James Yen Detection of dna hydroxymethylation
US9677128B2 (en) * 2010-10-22 2017-06-13 Oslo Universitetssykehus Hf Methods and kits for detection of 5-hydroxymethylcytosine
EP2633074A1 (en) 2010-10-27 2013-09-04 Quantibact A/s Capture of target dna and rna by probes comprising intercalator molecules
EP2681335A1 (en) 2011-03-04 2014-01-08 Brachmann, Andreas Novel methods for detecting hydroxymethylcytosine
US9145580B2 (en) 2011-04-02 2015-09-29 New England Biolabs, Inc. Methods and compositions for enriching either target polynucleotides or non-target polynucleotides from a mixture of target and non-target polynucleotides
WO2012138973A2 (en) 2011-04-06 2012-10-11 The University Of Chicago COMPOSITION AND METHODS RELATED TO MODIFICATION OF 5-METHYLCYTOSINE (5mC)
WO2012149047A1 (en) 2011-04-29 2012-11-01 Sequenom, Inc. Multimer glycosylated nucleic acid binding protein conjugates and uses thereof
JP2014520530A (ja) 2011-06-27 2014-08-25 フリアー システムズ, インコーポレイテッド 混合性核酸試料からの標的核酸の隔離
AU2012288629B2 (en) 2011-07-25 2017-02-02 Oxford Nanopore Technologies Limited Hairpin loop method for double strand polynucleotide sequencing using transmembrane pores
WO2013017853A2 (en) 2011-07-29 2013-02-07 Cambridge Epigenetix Limited Methods for detection of nucleotide modification
GB201119903D0 (en) 2011-11-17 2011-12-28 Univ Vilnius Nucleic acid production and sequence analysis
CN103131754B (zh) 2011-11-24 2014-07-30 深圳华大基因科技服务有限公司 一种检测核酸羟甲基化修饰的方法及其应用
EP2791361B9 (en) 2011-12-13 2018-07-11 Oslo Universitetssykehus HF Methods and kits for detection of methylation status
US20140179564A1 (en) 2012-11-01 2014-06-26 Pacific Biosciences Of California, Inc. Compositions and methods for selection of nucleic acids containing modified bases
US9238836B2 (en) 2012-03-30 2016-01-19 Pacific Biosciences Of California, Inc. Methods and compositions for sequencing modified nucleic acids
US9200260B2 (en) 2012-03-15 2015-12-01 New England Biolabs, Inc. Compositions and methods for the transfer of a hexosamine to a modified nucleotide in a nucleic acid
EP2825645B1 (en) 2012-03-15 2016-10-12 New England Biolabs, Inc. Methods and compositions for discrimination between cytosine and modifications thereof, and for methylome analysis
US10081827B2 (en) 2012-03-15 2018-09-25 New England Biolabs, Inc. Mapping cytosine modifications
US9175348B2 (en) 2012-04-24 2015-11-03 Pacific Biosciences Of California, Inc. Identification of 5-methyl-C in nucleic acid templates
WO2013185137A1 (en) 2012-06-08 2013-12-12 Pacific Biosciences Of California, Inc. Modified base detection with nanopore sequencing
WO2013188436A1 (en) 2012-06-11 2013-12-19 The Brigham And Women's Hospital, Inc. System and method for detecting cancer
GB201212047D0 (en) 2012-07-05 2012-08-22 Fermentas Uab Restriction endonucleases and their use
US10706957B2 (en) 2012-09-20 2020-07-07 The Chinese University Of Hong Kong Non-invasive determination of methylome of tumor from plasma
US9732390B2 (en) 2012-09-20 2017-08-15 The Chinese University Of Hong Kong Non-invasive determination of methylome of fetus or tumor from plasma
US20150307542A1 (en) 2012-10-03 2015-10-29 Moderna Therapeutics, Inc. Modified nucleic acid molecules and uses thereof
CA2898151C (en) 2013-01-22 2021-05-25 Centre National De La Recherche Scientific (Cnrs) Process for detection of dna modifications and protein binding by single molecule manipulation
US20140272970A1 (en) 2013-03-15 2014-09-18 Promega Corporation Method for quantifying 5-hydroxymethylcytosine
US10435740B2 (en) * 2013-04-01 2019-10-08 University Of Florida Research Foundation, Incorporated Determination of methylation state and chromatin structure of target genetic loci
WO2014191981A1 (en) 2013-05-28 2014-12-04 Ramot At Tel-Aviv University Ltd. Detection of hydroxymethylcytosine bases
EP3013979B1 (en) 2013-06-26 2017-04-05 Universität Konstanz Direct, programmable detection of epigenetic dna cytosine modifications using tal effectors
WO2014210444A1 (en) 2013-06-28 2014-12-31 New England Biolabs, Inc. Compositions and methods for identifying hydroxymethylcytosine in a dna
WO2015021282A1 (en) 2013-08-09 2015-02-12 New England Biolabs, Inc. Detecting, sequencing and/or mapping 5-hydroxymethylcytosine and 5-formylcytosine at single-base resolution
US20150167017A1 (en) 2013-12-13 2015-06-18 Moderna Therapeutics, Inc. Alternative nucleic acid molecules and uses thereof
EP3092308A1 (en) 2014-01-07 2016-11-16 Fundacio Privada Institut de Medicina Predictiva i Personalitzada del Cancer Method for generating double stranded dna libraries and sequencing methods for the identification of methylated cytosines
EP3137633A4 (en) 2014-04-28 2017-11-29 Sigma-Aldrich Co. LLC Epigenetic modification of mammalian genomes using targeted endonucleases
US20170175129A1 (en) 2014-06-19 2017-06-22 Moderna Therapeutics, Inc. Alternative nucleic acid molecules and uses thereof
US10421998B2 (en) * 2014-09-29 2019-09-24 The Regents Of The University Of California Nanopore sequencing of polynucleotides with multiple passes
US11198855B2 (en) * 2014-11-13 2021-12-14 The Board Of Trustees Of The University Of Illinois Bio-engineered hyper-functional “super” helicases
WO2016164363A1 (en) * 2015-04-06 2016-10-13 The Regents Of The University Of California Methods for determing base locations in a polynucleotide
EP3307755A4 (en) 2015-05-12 2018-12-26 Wake Forest University Health Sciences Identification of genetic modifications
US11396672B2 (en) 2015-08-31 2022-07-26 The University Of Chicago Composition and methods for detecting adenosine modifications
US20180251815A1 (en) 2015-09-04 2018-09-06 The University Of Tokyo Oxidizing agent for 5-hydroxymethylcytosine and method for analyzing 5-hydroxymethylcytosine
WO2017049166A1 (en) 2015-09-17 2017-03-23 Novartis Ag Car t cell therapies with enhanced efficacy
US10260088B2 (en) 2015-10-30 2019-04-16 New England Biolabs, Inc. Compositions and methods for analyzing modified nucleotides
WO2017075436A1 (en) 2015-10-30 2017-05-04 New England Biolabs, Inc. Compositions and methods for determining modified cytosines by sequencing
EP3374524A4 (en) 2015-11-11 2019-06-26 Ramot at Tel-Aviv University Ltd. PROCESS FOR DETECTION OF 5-HYDROXYMETHYLCYTOSINE AND FOR DIAGNOSIS OF CANCER
US11001976B2 (en) 2015-11-16 2021-05-11 Baron Innovative Technologies Lp Floats, float assemblies, float adapters and interfaces, and float vibration apparatus, and methods
US20210214781A1 (en) 2016-02-14 2021-07-15 Abhijit Ajit Patel Measurement of nucleic acid
EP3214183B1 (en) 2016-03-01 2018-11-21 Universität Konstanz Transcription activator-like effector (tale)-based decoding of cytosine nucleobases by selective modification response
US11162139B2 (en) 2016-03-02 2021-11-02 Shanghai Epican Genetech Co. Ltd. Method for genomic profiling of DNA 5-methylcytosine and 5-hydroxymethylcytosine
DK3440205T3 (da) 2016-04-07 2021-08-16 Univ Leland Stanford Junior Ikke-invasiv diagnostik ved sekventering af 5-hydroxymethyleret cellefrit dna
US20170298422A1 (en) 2016-04-18 2017-10-19 The Board Of Trustees Of The Leland Stanford Junior University Simultaneous single-molecule epigenetic imaging of dna methylation and hydroxymethylation
CN116445593A (zh) 2016-08-10 2023-07-18 格里尔公司 测定一生物样品的一甲基化图谱的方法
US11192929B2 (en) * 2016-12-08 2021-12-07 Regents Of The University Of Minnesota Site-specific DNA base editing using modified APOBEC enzymes
GB2559319B (en) 2016-12-23 2019-01-16 Cs Genetics Ltd Reagents and methods for the analysis of linked nucleic acids
US20200190581A1 (en) 2017-01-04 2020-06-18 The University Of Chicago Methods for detecting cytosine modifications
WO2018165459A1 (en) 2017-03-08 2018-09-13 The University Of Chicago Method for highly sensitive dna methylation analysis
WO2018165366A1 (en) 2017-03-08 2018-09-13 President And Fellows Of Harvard College Methods of amplifying dna to maintain methylation status
US20200063194A1 (en) 2017-04-03 2020-02-27 The Trustees Of Columbia University In The City Of New York Comprehensive single molecule enhanced detection of modified cytosines
US10155939B1 (en) 2017-06-15 2018-12-18 New England Biolabs, Inc. Method for performing multiple enzyme reactions in a single tube
WO2019013613A2 (es) 2017-07-09 2019-01-17 Hakken Enterprise Sa De Cv Métodos y kits para determinar el riesgo de cáncer
AU2018328324A1 (en) 2017-09-11 2020-04-30 Ludwig Institute For Cancer Research Ltd Selective labeling of 5-methylcytosine in circulating cell-free DNA
WO2019060722A2 (en) * 2017-09-22 2019-03-28 X Gen Us Co. METHODS AND COMPOSITIONS FOR USE IN PREPARING POLYNUCLEOTIDES
EP3710596B1 (en) * 2017-11-16 2023-08-02 New England Biolabs, Inc. Mapping the location, type and strand of damaged nucleotides in double-stranded dna
WO2019136413A1 (en) 2018-01-08 2019-07-11 Ludwig Institute For Cancer Research Ltd Bisulfite-free, base-resolution identification of cytosine modifications
US11634748B2 (en) 2018-02-14 2023-04-25 Clearnote Health, Inc. Methods for the epigenetic analysis of DNA, particularly cell-free DNA
JP2022530289A (ja) * 2019-04-28 2022-06-28 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 酵素消化を用いて情報価値があるdna断片を濃縮するためのライブラリー調製のための方法
GB201911515D0 (en) 2019-08-12 2019-09-25 Univ London Queen Mary Methods for generating a population of polynucleotide molecules
EP4038200A4 (en) 2019-09-30 2023-01-18 Integrated DNA Technologies, Inc. METHODS FOR PREPARING DUAL-INDEXED METHYL-SEQ LIBRARIES
EP3959342A4 (en) 2019-12-23 2023-05-24 Active Motif, Inc. METHODS AND KITS FOR ENRICHMENT AND DETECTION OF DNA AND RNA MODIFICATIONS AND FUNCTIONAL MOTORS
US11920190B2 (en) 2019-12-30 2024-03-05 Industrial Technology Research Institute Method of amplifying and determining target nucleotide sequence
WO2021178893A2 (en) 2020-03-06 2021-09-10 Singular Genomics Systems, Inc. Linked paired strand sequencing
WO2022023753A1 (en) 2020-07-30 2022-02-03 Cambridge Epigenetix Limited Compositions and methods for nucleic acid analysis

Also Published As

Publication number Publication date
AU2021319150A1 (en) 2023-03-02
EP4034676A1 (en) 2022-08-03
US20220298551A1 (en) 2022-09-22
CN116323977A (zh) 2023-06-23
US11608518B2 (en) 2023-03-21
JP2023535636A (ja) 2023-08-18
EP4083231A1 (en) 2022-11-02
US20220290215A1 (en) 2022-09-15
KR20230083269A (ko) 2023-06-09
IL300238A (en) 2023-03-01
WO2022023753A1 (en) 2022-02-03
US20240076720A1 (en) 2024-03-07
CA3187549A1 (en) 2022-02-03

Similar Documents

Publication Publication Date Title
MX2023001142A (es) Composiciones y metodos para analisis de acidos nucleicos.
MX2021003712A (es) Reducción de arn basada en nucleasa.
EP4339299A3 (en) Methods for determining a location of a target nucleic acid in a biological sample
Kawaji et al. Comparison of CAGE and RNA-seq transcriptome profiling using clonally amplified and single-molecule next-generation sequencing
IN2015DN01126A (es)
DE60315043D1 (de) Nachweis biologischer moleküle mittels differentieller aufteilung von enzymsubstraten und -produkten
ATE358733T1 (de) Schnell-verfahren zur detektion von mikroorganismen in lebensmittelproben
HK1098789A1 (en) Method for detecting and quantifying rare mutations/polymorphisms
EA201300072A1 (ru) Диагностика фетальной хромосомной анэуплоидии
WO2000077260A8 (en) Genomic profiling: a rapid method for testing a complex biological sample for the presence of many types of organisms
DE60142254D1 (de) Zusammensetzungen, methoden und reagentien zur nukleinsäureisolierung mittels oberflächenaktiven substanzen und proteasen
WO2005023091A3 (en) Method for non-invasive prenatal diagnosis
Holtkötter et al. Independent validation of body fluid-specific CpG markers and construction of a robust multiplex assay
JP2019520037A5 (es)
WO2022020751A3 (en) Methods for screening biological samples for contamination
WO2020072829A3 (en) Simultaneous, sequencing-based analysis of proteins, nucleosomes, and cell-free nucleic acids from a single biological sample
Costa-Alcalde et al. Comparative evaluation of the identification of rapidly growing non-tuberculous mycobacteria by mass spectrometry (MALDI-TOF MS), GenoType Mycobacterium CM/AS assay and partial sequencing of the rpoβ gene with phylogenetic analysis as a reference method
NO20052544L (no) Produkt og fremgangsmate.
CL2022000126A1 (es) Polinucleótidos para la amplificación y detección de neisseria gonorrhoeae
Sophian DNA Isolation of Chicken Feathers from the Base of the Young Feathers, the Base of the Old Feathers, and the Tip of the Feathers
ATE476440T1 (de) Hybridisierung von pna-sonden in alkohollösungen
CN105018639A (zh) 胃癌预后新型分子标志物lncRNA-AB007962的检测及用途
Lin et al. Mod-seq: A high-throughput method for probing RNA secondary structure
DE602004019059D1 (de) Methode zur linearen nicht-selektiven amplifikation von nukleinsäuren
Holt et al. Mitochondrial DNA data analysis strategies that inform MPS-based forensic casework implementation